An editor has nominated this article for deletion. You are welcome to participate in the deletion discussion, which will decide whether or not to retain it. |
Company type | Private |
---|---|
Industry | Venture capital |
Founded | February 2021 |
Founder | Maximillian Naza |
Headquarters | , |
Products | Investments |
Website | https://bias.capital/ |
Bias Capital, LLC (commonly known as Bias Capital) is an American venture capital firm that invests in both early-stage start-ups and established growth companies. In addition to its primary investments, the firm operates an angel syndicate, offering accredited investors and qualified purchasers the opportunity to access and participate in select investment opportunities.[1]
Bias Capital operates as the venture capital arm of PasciVite.
Notable Investments
In July 2023, Bias Capital led a $25 million Series A funding round for Parker Health, a biotech company focused on revolutionizing electronic health records and healthcare management.[2]
Other notable investments include Grabango, Wayflyer, Fintor, Valtivis, Flower CO. and FLYR.[3]
References
- ^ "Bias Capital". 2021-10-06. Archived from the original on 2021-10-06. Retrieved 2024-12-16.
{{cite web}}
: CS1 maint: bot: original URL status unknown (link) - ^ "Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare". Archived from the original on 2024-10-05. Retrieved 2024-12-13.
- ^ "Bias Capital Investment Portfolio | PitchBook". pitchbook.com. Retrieved 2024-12-16.
- American companies established in 2021
- Companies based in San Francisco
- Financial services companies based in California
- Financial services companies established in 2021
- Privately held companies based in California
- Venture capital firms
- Venture capital firms of the United States
- 2021 establishments in California